Jane A. Dobbin

417 total citations
6 papers, 97 citations indexed

About

Jane A. Dobbin is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Oncology. According to data from OpenAlex, Jane A. Dobbin has authored 6 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 3 papers in Genetics and 2 papers in Oncology. Recurrent topics in Jane A. Dobbin's work include Acute Lymphoblastic Leukemia research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Acute Myeloid Leukemia Research (1 paper). Jane A. Dobbin is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Acute Myeloid Leukemia Research (1 paper). Jane A. Dobbin collaborates with scholars based in Brazil, United States and Sao Tome and Principe. Jane A. Dobbin's co-authors include Maria S. Pombo‐de‐Oliveira, Raquel Ciuvalschi Maia, Eny Carvalho, Lílian Maria Cristófani, Luíz Gonzaga Tone, Marcos Borato Viana, Sílvia Regina Brandalise, José Andrés Yunes, Luiz Fernando Lopes and Algemir Lunardi Brunetto and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Tumor Biology.

In The Last Decade

Jane A. Dobbin

6 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jane A. Dobbin Brazil	3	52	43	24	22	15	6	97
Ibrahim Ghemlas Saudi Arabia	6	38 0.7×	26 0.6×	15 0.6×	57 2.6×		29	109
M. Stanulla Germany	4	111 2.1×	46 1.1×	22 0.9×	75 3.4×		4	145
Tamara Law Australia	6	108 2.1×	53 1.2×	15 0.6×	83 3.8×		15	149
Arnaud Dalissier France	6	67 1.3×	39 0.9×	17 0.7×	85 3.9×		13	109
A. Yu. Romanov Russia	7	28 0.5×	20 0.5×	20 0.8×	5 0.2×		21	132
M. van Weel‐Sipman Netherlands	4	28 0.5×	25 0.6×	5 0.2×	37 1.7×		5	84
Lizamarie Bachier‐Rodriguez United States	4	10 0.2×	8 0.2×	11 0.5×	32 1.5×	3 0.2×	21	59
Barry A. Ripps United States	10	89 1.7×	28 0.7×	123 5.1×	4 0.2×		15	299
Anderson Kuntz Grzesiuk Brazil	5	38 0.7×	12 0.3×	71 3.0×	8 0.4×	2 0.1×	13	150

Countries citing papers authored by Jane A. Dobbin

Since Specialization

Citations

This map shows the geographic impact of Jane A. Dobbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane A. Dobbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane A. Dobbin more than expected).

Fields of papers citing papers by Jane A. Dobbin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane A. Dobbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane A. Dobbin. The network helps show where Jane A. Dobbin may publish in the future.

Co-authorship network of co-authors of Jane A. Dobbin

This figure shows the co-authorship network connecting the top 25 collaborators of Jane A. Dobbin. A scholar is included among the top collaborators of Jane A. Dobbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane A. Dobbin. Jane A. Dobbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Brandalise, Sílvia Regina, José Andrés Yunes, Eny Carvalho, et al.. (2010). Benefits of the Intermittent Use of 6-Mercaptopurine and Methotrexate in Maintenance Treatment for Low-Risk Acute Lymphoblastic Leukemia in Children: Randomized Trial From the Brazilian Childhood Cooperative Group—Protocol ALL-99. Journal of Clinical Oncology. 28(11). 1911–1918. 63 indexed citations

2.

Velasco, Eduardo, et al.. (2007). The Prognostic Role of Clinical and Microbiological Factors on Mortality Related to Candida Bloodstream Infections in Hospitalized Patients with Hematologic Malignancies.. Blood. 110(11). 3861–3861. 1 indexed citations

3.

Dobbin, Jane A.. (2005). Transformação da LLC-B: síndrome de Richter. Revista Brasileira de Hematologia e Hemoterapia. 27(4). 1 indexed citations

4.

Pombo‐de‐Oliveira, Maria S., Jane A. Dobbin, Paula Loureiro, et al.. (2002). Genetic mutation and early onset of T-cell leukemia in pediatric patients infected at birth with HTLV-I. Leukemia Research. 26(2). 155–161. 22 indexed citations

5.

Maia, Raquel Ciuvalschi, et al.. (1998). Comparison between Anthracyclines and Rhodamine-123 Accumulation in Chronic Lymphoid Leukemia: Effect of Cyclosporin A and Verapamil. Tumor Biology. 19(1). 41–51. 8 indexed citations

6.

Gil, Roberto Almeida, Juan Martino, Jane A. Dobbin, et al.. (1994). Long-Term Results with MACOP-B in the Treatment of Aggressive Non-Hodgkinʼs Lymphomas. American Journal of Clinical Oncology. 17(4). 323–327. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact